DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/s2nhq5/2016_emerging) has announced the addition of the "2016 Emerging Strategies for the US Home/Self Testing Diagnostics Market" report to their offering.
This new 175-page report provides analysis of themajor home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation, and occult blood. The report presents trends, dynamics, size, growth, regulatory requirements, technologies, and competitive profiles.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.
Market Segmentation Analysis
- Review of the home/self testing market segments, including diabetes (strips and meters), pregnancy, ovulation and occult blood.
- Five-year sales forecasts.
- Assessments of major POC suppliers and emerging market entrants.
- Abbott- Affymetrix- Beckman Coulter/Danaher- Becton Dickinson- bioMerieux- Bio-Rad- Cepheid- Diamedix- DiaSorin- Eiken Chemical- Elitech Group- Enzo Biochem- Fujirebio- Grifols- Hologic/Gen-Probe- ID Biomedical/GSK- Kreatech/Leica- Lonza- Ortho-Clinical Diagnostics- Qiagen- Roche- Scienion- Sequenom- SeraCare- Siemens- Takara Bio- Thermo Fisher/Life Technology- Wallac/PE- Wako
For more information visit http://www.researchandmarkets.com/research/s2nhq5/2016_emerging
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets